New Trial Tests Clot-Removal Treatment for Mild Strokes Caused by Blocked Arteries

The New England Journal of Medicine posted details of the MILD-MT trial, which looked at a group of stroke patients whose symptoms were relatively minor despite having a significant blockage in a large blood vessel supplying the brain. The trial tests whether going beyond standard clot-dissolving drugs to physically retrieve the clot produces better recovery.

Endovascular therapy — sometimes called mechanical thrombectomy — involves threading a thin tube through an artery, usually from the wrist or groin, to reach the blocked vessel and pull the clot out. It’s already standard care for more severe strokes caused by large-vessel occlusion (a blockage in one of the brain’s main arteries). What the MILD-MT trial asks is whether patients with milder initial symptoms deserve the same approach.

That question matters. Some patients arrive at hospital with what appears to be a mild stroke but carry a large clot that can cause greater damage as time passes. Treating them aggressively early could prevent deterioration — but the procedure carries its own risks, and the balance of benefit versus harm in this lower-severity group has not been clear.

The trial is published under the neurology and emergency medicine fields, reflecting that decisions about endovascular treatment are typically made fast, often within hours of symptoms starting.

If you or someone nearby develops sudden facial drooping, arm weakness, or slurred speech — the FAST signs — call 999 immediately. Time is critical in all stroke cases. For non-emergency questions about stroke risk or recovery, contact your GP or call NHS 111.

Key information

• Stroke emergency: Call 999 if you notice FAST signs — Face drooping, Arm weakness, Speech problems, Time to call
• Non-emergency health advice: NHS 111, available 24 hours a day
• Stroke Association helpline: 0303 3033 100